abstract |
Novel compounds represented by formula I: n n n wherein Y, Z, X, W, R 1 , R 2 and R 3 are as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity and the treatment or prevention of diseases associated therewith. |